Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-15-067380

Chief Operating Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Higgons John Duncan · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-08-20 Exercise or conversion : show line 1 in the form +10,000 $0.30 $3,025 141,835 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-08-20 Exercise or conversion : show line 2 in the form Stock option (right to buy) −10,000 $0.30 2019-08-12 10,000 275,022 D
Loading xslF345X03/doc4.xml…